Communication

News

ImCheck Therapeutics – new member

23 December 2019
New member

 ImCheck Therapeutics is driving innovation in two powerful new areas of immune system modulation: the butyrophilins superfamily of immunomodulatory molecules and gamma-delta T cells. To know more